Indian J Pharm Close
 

Figure 5: (a) Kaplan–Meier analysis of the survival probability based on the type of surgery and the chemotherapy administered. The total number of cases per group is depicted at the far left and was the starting number. The number of survivors at the end of each year was mentioned under each time point. (b) Percent survival of triple-negative breast cancer cases per year based on the stage of cancer depicted by Kaplan–Meier survival curves. The number of cases per stage is shown at the far left and is the starting numbers for the analysis. The number of survivors at the end of every year is mentioned under each time point

Figure 5: (a) Kaplan–Meier analysis of the survival probability based on the type of surgery and the chemotherapy administered. The total number of cases per group is depicted at the far left and was the starting number. The number of survivors at the end of each year was mentioned under each time point. (b) Percent survival of triple-negative breast cancer cases per year based on the stage of cancer depicted by Kaplan–Meier survival curves. The number of cases per stage is shown at the far left and is the starting numbers for the analysis. The number of survivors at the end of every year is mentioned under each time point